vimarsana.com

Latest Breaking News On - Rick winningham - Page 1 : vimarsana.com

Theravance Biopharma, Inc to Host Virtual Key Opinion Leader (KOL) Event to Discuss Ampreloxetine s Potential for the Treatment of Symptomatic Neurogenic Orthostatic Hypotension (nOH) in Patients with Multiple System Atrophy (MSA) on May 23, 2024

Theravance Biopharma, Inc (NASDAQ:TBPH) Q4 2023 Earnings Call Transcript

Beleaguered Theravance logs head-to-head trial loss for Yupelri against Boehringer s Spiriva

Beleaguered Theravance logs head-to-head trial loss for Yupelri against Boehringer s Spiriva
fiercepharma.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from fiercepharma.com Daily Mail and Mail on Sunday newspapers.

Theravance Biopharma: Phase 4 PIFR-2 Study Fails To Meet Primary Endpoint

Theravance Biopharma, Inc. (TBPH) announced results from the Phase 4 PIFR-2 study of YUPELRI inhalation solution, the nebulized long-acting muscarinic antagonist approved in the U.

Theravance Biopharma, Inc (NASDAQ:TBPH) Q3 2023 Earnings Call Transcript

Theravance Biopharma, Inc. (NASDAQ:TBPH) Q3 2023 Earnings Call Transcript November 7, 2023 Operator: Ladies and gentlemen, good afternoon. I’d like to welcome everyone to Theravance Biopharma’s Third Quarter 2023 Conference Call. During the presentation, all participants will be in a listen-only mode. A question-and-answer session will follow the company’s formal remarks. [Operator Instructions] Also, today’s […]

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.